A novel role for c-Myc in G protein-coupled receptor kinase 4 (GRK4) transcriptional regulation in human kidney proximal tubule cells

Hypertension

Volumn 61, Issue 5, 2013, Pages 1021-1027

  Gildea, John J ^a   Tran, Hanh T ^a   Van Sciver, Robert E ^a   Wang, Dora Bigler ^a   Carlson, Julia M ^a   Felder, Robin A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

angiotensins; c Myc genes; cAMP receptor protein; dopamine; losartan; promoter regions, genetic; renin angiotensin system

Indexed keywords

10074 G5; ANGIOTENSIN II; G PROTEIN COUPLED RECEPTOR KINASE 4; GLUTAMYL AMINOPEPTIDASE; LOSARTAN; MYC PROTEIN; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; AUTOCRINE EFFECT; CELLULAR SECRETION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; KIDNEY CELL; KIDNEY PROXIMAL TUBULE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRANSCRIPTION REGULATION;

ANGIOTENSIN II; CELL LINE; CELLS, CULTURED; G-PROTEIN-COUPLED RECEPTOR KINASE 4; HUMANS; KIDNEY TUBULES, PROXIMAL; LOSARTAN; OXADIAZOLES; PHORBOL ESTERS; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, DOPAMINE; TRANSCRIPTION, GENETIC;

EID: 84876679670     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.00321     Document Type: Article

References (32)

1. Pelayo JC, Fildes RD, Eisner GM, Jose PA. Effects of dopamine blockade on renal sodium excretion. Am J Physiol. 1983;245:F247-F253.
2. Siragy HM, Felder RA, Howell NL, Chevalier RL, Peach MJ, Carey RM. Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol. 1989;257(3 Pt 2):F469-F477.
3. Wang X, Villar VA, Armando I, Eisner GM, Felder RA, Jose PA. Dopamine, kidney, and hypertension: studies in dopamine receptor knockout mice. Pediatr Nephrol. 2008;23:2131-2146.
4. Gildea JJ, Israel JA, Johnson AK, Zhang J, Jose PA, Felder RA. Caveolin-1 and dopamine-mediated internalization of NaKATPase in human renal proximal tubule cells. Hypertension. 2009;54:1070-1076.
5. Gildea JJ, Shah I, Weiss R, Casscells ND, McGrath HE, Zhang J, Jones JE, Felder RA. HK-2 human renal proximal tubule cells as a model for G protein-coupled receptor kinase type 4-mediated dopamine 1 receptor uncoupling. Hypertension. 2010;56:505-511.
6. Rankin ML, Marinec PS, Cabrera DM, Wang Z, Jose PA, Sibley DR. The D1 dopamine receptor is constitutively phosphorylated by G protein-coupled receptor kinase 4. Mol Pharmacol. 2006;69:759-769.
7. Sanada H, Yatabe J, Midorikawa S, Katoh T, Hashimoto S, Watanabe T, Xu J, Luo Y, Wang X, Zeng C, Armando I, Felder RA, Jose PA. Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression. Hypertension. 2006;47:1131-1139.
8. Yatabe J, Sanada H, Midorikawa S, Hashimoto S, Watanabe T, Andrews PM, Armando I, Wang X, Felder RA, Jose PA. Effects of decreased renal cortical expression of G protein-coupled receptor kinase 4 and angioten-sin type 1 receptors in rats. Hypertens Res. 2008;31:1455-1464.
9. Hasenkamp S, Telgmann R, Staessen JA, Hagedorn C, Dördelmann C, Bek M, Brand-Herrmann SM, Brand E. Characterization and functional analyses of the human G protein-coupled receptor kinase 4 gene promoter. Hypertension. 2008;52:737-746.
10. Buendia MA, Bourre L, Cairo S. Myc target miRs and liver cancer: small molecules to get Myc sick. Gastroenterology. 2012;142:214-218.
11. Lee HG, Chen Q, Wolfram JA, et al. Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failure. PLoS ONE. 2009;4:e7172.
12. Bello Roufai M, Li H, Sun Z. Heart-specifc inhibition of protoonco-gene c-myc attenuates cold-induced cardiac hypertrophy. Gene Ther. 2007;14:1406-1416.
13. de Nigris F, Balestrieri ML, Napoli C. Targeting c-Myc, Ras and IGF cascade to treat cancer and vascular disorders. Cell Cycle. 2006;5:1621-1628.
14. Li Z, Van Calcar S, Qu C, Cavenee WK, Zhang MQ, Ren B. A global tran-scriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci USA. 2003;100:8164-8169.
15. Bernstein SH, Kharbanda SM, Sherman ML, Stone RM, Kufe DW. Inhibition of protein kinase C is associated with a decrease in c-myc expression in human myeloid leukemia cells. FEBS Lett. 1991;294:73-76.
16. Gildea JJ, Wang X, Shah N, Tran H, Spinosa M, Van Sciver R, Sasaki M, Yatabe J, Carey RM, Jose PA, Felder RA. Dopamine and angiotensin type 2 receptors cooperatively inhibit sodium transport in human renal proximal tubule cells. Hypertension. 2012;60:396-403.
17. Kowolik CM, Liang S, Yu Y, Yee JK. Cre-mediated reversible immortalization of human renal proximal tubular epithelial cells. Oncogene. 2004;23:5950-5957.
18. Wieser M, Stadler G, Jennings P, Streubel B, Pfaller W, Ambros P, Riedl C, Katinger H, Grillari J, Grillari-Voglauer R. hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. Am J Physiol Renal Physiol. 2008;295:F1365-F1375.
19. Kamiyama M, Garner MK, Farragut KM, Kobori H. The establishment of a primary culture system of proximal tubule segments using specifc markers from normal mouse kidneys. Int J Mol Sci. 2012;13:5098-5111.
20. Kamiyama M, Farragut KM, Garner MK, Navar LG, Kobori H. Divergent localization of angiotensinogen mRNA and protein in proximal tubule segments of normal rat kidney. J Hypertens. 2012;30:2365-2372.
21. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1419-1424.
22. Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, Mezzano S, Egido J. Angiotensin II regulates the synthesis of proinfammatory cyto-kines and chemokines in the kidney. Kidney Int Suppl. 2002:S12-S22.
23. Chen J, Chen JK, Nagai K, Plieth D, Tan M, Lee TC, Threadgill DW, Neilson EG, Harris RC. EGFR signaling promotes TGFβ-dependent renal fbrosis. J Am Soc Nephrol. 2012;23:215-224.
24. Gildea JJ. Dopamine and angiotensin as renal counterregulatory systems controlling sodium balance. Curr Opin Nephrol Hypertens. 2009;18:28-32.
25. Zeng C, Jose PA. Dopamine receptors: important antihypertensive counterbalance against hypertensive factors. Hypertension. 2011;57:11-17.
26. Johnson AD, Newton-Cheh C, Chasman DI, et al.; Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium; Global BPgen Consortium; Women's Genome Health Study. Association of hypertension drug target genes with blood pressure and hypertension in 86, 588 individuals. Hypertension. 2011;57:903-910.
27. Wolf G, Neilson EG. Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am J Physiol. 1990;259(5 Pt 2):F768-F777.
28. Lindsten T, June CH, Thompson CB. Multiple mechanisms regulate c-myc gene expression during normal T cell activation. EMBO J. 1988;7:2787-2794.
29. Felder RA, Sanada H, Xu J, et al. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA. 2002;99:3872-3877.
30. Zeng C, Luo Y, Asico LD, Hopfer U, Eisner GM, Felder RA, Jose PA. Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats. Hypertension. 2003;42:787-792.
31. Khan F, Spicarová Z, Zelenin S, Holtbäck U, Scott L, Aperia A. Negative reciprocity between angiotensin II type 1 and dopamine D1 receptors in rat renal proximal tubule cells. Am J Physiol Renal Physiol. 2008;295:F1110-F1116.
32. Soucek L, Whitfeld J, Martins CP, Finch AJ, Murphy DJ, Sodir NM, Karnezis AN, Swigart LB, Nasi S, Evan GI. Modelling Myc inhibition as a cancer therapy. Nature. 2008;455:679-683.